Avastin’s Off-Label Uptake May Be Slowed By ASP-Based Reimbursement
This article was originally published in The Pink Sheet Daily
Executive Summary
Medicare reimbursement changes make oncologists more likely to adhere to established treatment guidelines, Robert W. Baird analyst says.